Cidara Therapeutics, Inc. - Common Stock (NQ:CDTX)

221.38 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cidara Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

CDTX LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – CDTX

April 25, 2024

From The Rosen Law Firm, P.A.

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

April 25, 2024

Pre-market stock movers are a great way to start Thursday as we check out all of the hottest news moving shares this morning!

Via InvestorPlace

Why Teradyne Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket ↗

April 25, 2024

Via Benzinga

Why Cidara Therapeutics (CDTX) Stock Is Falling ↗

April 22, 2024

Cidara Therapeutics shares are trading lower by 24.4% Monday afternoon. The company announced a 1-for-20 reverse stock split.

Via Benzinga

6 Analysts Have This to Say About Cidara Therapeutics ↗

May 12, 2023

Via Benzinga

Recap: Cidara Therapeutics Q1 Earnings ↗

May 11, 2023

Via Benzinga

Analyst Ratings for Cidara Therapeutics ↗

April 18, 2023

Via Benzinga

Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 23, 2024

Via Benzinga

Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket ↗

April 23, 2024

Via Benzinga

CDTX Stock Earnings: Cidara Therapeutics Beats EPS, Beats Revenue for Q4 2023 ↗

April 22, 2024

CDTX stock results show that Cidara Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 30, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 25, 2023

Via Benzinga

Crude Oil Rises Over 1%; Cidara Therapeutics Shares Spike Higher ↗

September 06, 2023

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 1% on Wednesday. The Dow traded down 0.57% to 34,443.02 while the NASDAQ fell 1.19% to 13,853.60. The S&P...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 06, 2023

Via Benzinga

Why Core & Main Are Trading Lower By 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

September 06, 2023

Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 114% to $1.47. Palisade Bio transformed GI-focused pipeline through exclusive worldwide licensing agreement with Giiant Pharma, Inc. for multiple...

Via Benzinga

Why Is Infectious Diseases Focused Cidara Therapeutics Stock Trading Higher Today? ↗

September 06, 2023

Cidara Therapeutics Inc (NASDAQ: CDTX) shares are trading higher after the company announced that Janssen Pharmaceuticals Inc, a unit of Johnson & Johnson (NYSE: JNJ), decided to pr

Via Benzinga

Want to Get Rich? 3 Game-Changing Penny Stocks to Buy Right Now ↗

August 28, 2023

While the very concept of penny stocks to buy is treacherous, these analyst-backed ideas could be enticing for the smart speculator.

Via InvestorPlace

Cidara Therapeutics And 3 Other Stocks Under $3 Insiders Are Buying ↗

August 09, 2023

The Dow Jones closed lower by over 150 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Janssen To Discontinue Internal Development Of Cidara Therapeutics-Partnered Influenza Candidate ↗

July 21, 2023

Cidara Therapeutics Inc (NASDAQ: CDTX) provided an update on the status of its ongoing CD388 program for the prevention of influenza A and B under an exclusive worldwide license and collaboration...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 22, 2023

Via Benzinga

Why Blue Bird Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket ↗

May 12, 2023

Gainers Getaround, Inc. (NYSE: GETR) shares surged 112% to $0.7020 in pre-market trading. Getaround acquired substantially all assets of HyreCar for an aggregate purchase price of $9.45 million.

Via Benzinga

Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 12, 2023

Gainers GSI Technology, Inc. (NASDAQ: GSIT) shares surged 108% to $3.4207. GSI Technology is expected to announce financial results for its fiscal fourth quarter after the market close on May 16,...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

May 12, 2023

It's time for another dive into the biggest pre-market stock movers traders need to know about as we cover the winners and losers for Friday!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 28, 2023

Via Benzinga

Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 28, 2023

Gainers

Via Benzinga

Why FreightCar America Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket ↗

March 28, 2023

Gainers Biodexa Pharmaceuticals (NASDAQ: BDRX) shares rose 76% to $0.8276 in pre-market trading after gaining 65% on Monday.

Via Benzinga

Cidara Therapeutics And 2 Other Stocks Under $2 Insiders Are Aggressively Buying ↗

March 28, 2023

The Dow Jones closed higher by around 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 24, 2023

Via Benzinga

Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 24, 2023

Gainers Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.